Citi Put 84 BNR 20.06.2024/ DE000KJ2Y053 /
09/04/2024 08:26:49 | Var.- | Denaro22:00:17 | Lettera22:00:17 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.04EUR | - | - Quantità in denaro: - |
- Quantità in lettera: - |
BRENNTAG SE NA O.N. | 84.00 - | 20/06/2024 | Put |
GlobeNewswire
13:48
Mounting Evidence that use of the Mental Health Collaborative Care Model is Associated with Reductio...
GlobeNewswire
13:45
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp
13:30
Cosa Resources Announces Summer Exploration Plans for Athabasca Basin Uranium Projects
GlobeNewswire
13:30
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
13:30
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire
13:30
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:30
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire
13:30
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
GlobeNewswire
13:30
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
13:30
Destination XL Group, Inc. to Announce First Quarter 2024 Financial Results on May 30, 2024
GlobeNewswire
13:30
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
13:30
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
GlobeNewswire
13:30
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024